Stock comparison
Alnylam Pharmaceuticals
ALNY$39.26BHealthcare Market cap, Sector
Jeena Sikho Lifecare Limited
JSLL.BO$72.13BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
ALNY 16 JSLL.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
ALNY1wins
6winsJSLL.BO
52D
B84
76B
A87
70B
A92
79B
C66
59D
B75
70B
A91
70B
A95
Side-by-side metrics
| Metric | ALNY | JSLL.BO |
|---|---|---|
| Market cap | $39.26B | $72.13B Winner |
| P/E (TTM) | 68.1x | 33.2x Winner |
| EV/EBIT | 77.8x | 24.1x Winner |
| ROIC (TTM) | 19.66% | 39.15% Winner |
| Gross margin | 80.89% | 88.58% Winner |
| Net margin | 13.46% | 27.68% Winner |
| Revenue CAGR 5y | 44.82% | 57.81% Winner |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | 1.2x | 0.3x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALNY leads on
No clear edges - the other side wins or ties on every measured metric.
JSLL.BO leads on
- Debt / Equity0.3xvs 1.2x+77%
- EV/EBIT24.1xvs 77.8x+69%
- Net margin27.68%vs 13.46%+51%
- P/E (TTM)33.2xvs 68.1x+51%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.